This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wang, Q. Articles by Beck, W. T. Search for Related Content PubMed PubMed Citation Articles by Wang, Q. Articles by Beck, W. T.

Transcriptional Suppression of Multidrug Resistance-associated Protein (MRP) Gene Expression by Wild-Type p53¹

Division of Developmental Therapeutics, Cancer Center, College of Medicine, University of Illinois at Chicago, Chicago, Illinois 60607

Multidrug resistance is a major obstacle to the success of cancer chemotherapy. The multidrug resistance-associated protein (MRP) has been shown to confer multidrug resistance. To study MRP gene expression at the transcriptional level, we have fused the MRP gene promoter with the luciferase reporter gene and studied its regulation. Cotrasfection of MRP promoter constructs with p53 expression plasmids in p53-null human H1299 and mouse (10)1 cells demonstrated that the wild-type (wt) p53 markedly suppressed MRP promoter activity, whereas mutant p53 had little inhibitory effect. Transfections using 5' deletion mutant constructs of the MRP promoter showed that inhibition of the promoter activity by wt p53 mainly resided in the region from -91 to +103 bp, where several Sp1 transcription factor binding sites are localized. Cotransfection of the MRP promoter into Drosophila SL2 cells with an Sp1 expression vector increased the promoter activity in a dose-related manner up to 200-fold. The stimulation of MRP promoter activity by Sp1 was attenuated by the cotransfection of a wt p53-expression plasmid. Furthermore, we have determined that endogenous MRP mRNA levels were down-regulated by restoration of wt p53-expression in a human lung cancer cell line. The relevance of MRP regulation in drug resistance was studied in a drug-resistant cell line, CEM/VM-1-5, that is 140-fold more resistant to the epipodophyllotoxin, teniposide (VM-26), than the parental CEM cells. CEM/VM-1-5 cells express a much higher amount of MRP mRNA and protein than CEM cells, indicating that the resistant phenotype is at least partly due to increased MRP production. Transient transfection of the promoter constructs revealed that CEM/VM-1-5 cells had higher (7-fold) MRP promoter activity than CEM cells. Cotransfection of a wt p53-expression plasmid caused a reduction of MRP promoter activity in both CEM and CEM/VM-1-5 cells, but the inhibition was more than double in CEM/VM-1-5 cells compared with CEM cells. Our results demonstrated that wt p53 acts as a negative regulator of MRP gene transcription, at least in part by diminishing the effect of a powerful transcription activator Sp1. Therefore, a loss of wt p53 function and/or an increase in Sp1 activity in tumor cells could contribute to an up-regulation of the MRP gene.

¹ Supported in part by NIH Grants CA40570 and CA30103 (to W. T. B.) and in part by the Cancer Center of the University of Illinois at Chicago.

² Present address: Department of Molecular Biosciences, School of Veterinary Medicine, University of California, Davis, 1311 Haring Hall, Davis, CA 95616.

³ To whom requests for reprints should be addressed, at Cancer Center (M/C 569), University of Illinois at Chicago, 900 South Ashland Avenue, Chicago, IL 60607. Phone: (312) 355-0827; Fax: (312) 355-0194; E-mail: wtbeck@uic.edu.

Received 5/ 1/98. Accepted 10/ 7/98.

This article has been cited by other articles:

				K. A. Brown, M. Dore, J. G. Lussier, and J. Sirois Human Chorionic Gonadotropin-Dependent Up-Regulation of Genes Responsible for Estrogen Sulfoconjugation and Export in Granulosa Cells of Luteinizing Preovulatory Follicles Endocrinology, September 1, 2006; 147(9): 4222 - 4233. [Abstract] [Full Text] [PDF]

				R. G. Deeley, C. Westlake, and S. P. C. Cole Transmembrane Transport of Endo- and Xenobiotics by Mammalian ATP-Binding Cassette Multidrug Resistance Proteins. Physiol Rev, July 1, 2006; 86(3): 849 - 899. [Abstract] [Full Text] [PDF]

				V. Marwaha, Y.-H. Chen, E. Helms, S. Arad, H. Inoue, E. Bord, R. Kishore, R. D. Sarkissian, B. A. Gilchrest, and D. A. Goukassian T-oligo Treatment Decreases Constitutive and UVB-induced COX-2 Levels through p53- and NF{kappa}B-dependent Repression of the COX-2 Promoter J. Biol. Chem., September 16, 2005; 280(37): 32379 - 32388. [Abstract] [Full Text] [PDF]

				J. T. Lee Jr., L. S. Steelman, and J. A. McCubrey Phosphatidylinositol 3'-Kinase Activation Leads to Multidrug Resistance Protein-1 Expression and Subsequent Chemoresistance in Advanced Prostate Cancer Cells Cancer Res., November 15, 2004; 64(22): 8397 - 8404. [Abstract] [Full Text] [PDF]

				S. Jorajuria, N. Dereuddre-Bosquet, K. Naissant-Storck, D. Dormont, and P. Clayette Differential Expression Levels of MRP1, MRP4, and MRP5 in Response to Human Immunodeficiency Virus Infection in Human Macrophages Antimicrob. Agents Chemother., May 1, 2004; 48(5): 1889 - 1891. [Abstract] [Full Text] [PDF]

				M. Muredda, K.-I. Nunoya, R. A. Burtch-Wright, E. U. Kurz, S. P. C. Cole, and R. G. Deeley Cloning and Characterization of the Murine and Rat mrp1 Promoter Regions Mol. Pharmacol., November 1, 2003; 64(5): 1259 - 1269. [Abstract] [Full Text] [PDF]

				O. Briz, R. I. R. Macias, M. Vallejo, A. Silva, M. A. Serrano, and J. J. G. Marin Usefulness of Liposomes Loaded with Cytostatic Bile Acid Derivatives to Circumvent Chemotherapy Resistance of Enterohepatic Tumors Mol. Pharmacol., March 1, 2003; 63(3): 742 - 750. [Abstract] [Full Text] [PDF]

				M. Wierdl, C. L. Morton, L. C. Harris, M. K. Danks, J. D. Schuetz, and P. M. Potter p53-Mediated Regulation of Expression of a Rabbit Liver Carboxylesterase Confers Sensitivity to 7-Ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (CPT-11) J. Pharmacol. Exp. Ther., February 1, 2003; 304(2): 699 - 705. [Abstract] [Full Text] [PDF]

				K.-i. Watanabe, T. Ozaki, T. Nakagawa, K. Miyazaki, M. Takahashi, M. Hosoda, S. Hayashi, S. Todo, and A. Nakagawara Physical Interaction of p73 with c-Myc and MM1, a c-Myc-binding Protein, and Modulation of the p73 Function J. Biol. Chem., April 19, 2002; 277(17): 15113 - 15123. [Abstract] [Full Text] [PDF]

				J. Sampath, D. Sun, V. J. Kidd, J. Grenet, A. Gandhi, L. H. Shapiro, Q. Wang, G. P. Zambetti, and J. D. Schuetz Mutant p53 Cooperates with ETS and Selectively Up-regulates Human MDR1 Not MRP1 J. Biol. Chem., October 12, 2001; 276(42): 39359 - 39367. [Abstract] [Full Text] [PDF]

				M. Pallis, M. Grundy, J. Turzanski, R. Kofler, and N. Russell Mitochondrial membrane sensitivity to depolarization in acute myeloblastic leukemia is associated with spontaneous in vitro apoptosis, wild-type TP53, and vicinal thiol/disulfide status Blood, July 15, 2001; 98(2): 405 - 413. [Abstract] [Full Text] [PDF]

				G. Wurzer, Z. Herceg, and J. Wsierska-Gadek Increased Resistance to Anticancer Therapy of Mouse Cells Lacking the Poly(ADP-ribose) Polymerase Attributable to Up-Regulation of the Multidrug Resistance Gene Product P-Glycoprotein Cancer Res., August 1, 2000; 60(15): 4238 - 4244. [Abstract] [Full Text]

				G. Pani, B. Bedogni, R. Anzevino, R. Colavitti, B. Palazzotti, S. Borrello, and T. Galeotti Deregulated Manganese Superoxide Dismutase Expression and Resistance to Oxidative Injury in p53-deficient Cells Cancer Res., August 1, 2000; 60(16): 4654 - 4660. [Abstract] [Full Text]

				C. L. Nutt, N. A. Loktionova, A. E. Pegg, A. F. Chambers, and J.g. Cairncross O6-Methylguanine-DNA methyltransferase activity, p53 gene status and BCNU resistance in mouse astrocytes Carcinogenesis, December 1, 1999; 20(12): 2361 - 2365. [Abstract] [Full Text] [PDF]

				M. Filipits, J. Drach, G. Pohl, J. Schuster, T. Stranzl, J. Ackermann, R. Konigsberg, H. Kaufmann, H. Gisslinger, H. Huber, et al. Expression of the Lung Resistance Protein Predicts Poor Outcome in Patients with Multiple Myeloma Clin. Cancer Res., September 1, 1999; 5(9): 2426 - 2430. [Abstract] [Full Text] [PDF]

				B. C. Ding, J. R. Whetstine, T. L. Witt, J. D. Schuetz, and L. H. Matherly Repression of Human Reduced Folate Carrier Gene Expression by Wild Type p53 J. Biol. Chem., March 16, 2001; 276(12): 8713 - 8719. [Abstract] [Full Text] [PDF]

				E. C. Thornborrow and J. J. Manfredi The Tumor Suppressor Protein p53 Requires a Cofactor to Activate Transcriptionally the Human BAX Promoter J. Biol. Chem., May 4, 2001; 276(19): 15598 - 15608. [Abstract] [Full Text] [PDF]

				B. Li and M. Y. W. Lee Transcriptional Regulation of the Human DNA Polymerase delta Catalytic Subunit Gene POLD1 by p53 Tumor Suppressor and Sp1 J. Biol. Chem., August 3, 2001; 276(32): 29729 - 29739. [Abstract] [Full Text] [PDF]